BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11682251)

  • 1. Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.
    Rice OV; Gatley SJ; Shen J; Huemmer CL; Rogoz R; DeJesus OT; Volkow ND; Gifford AN
    Neuropsychopharmacology; 2001 Nov; 25(5):679-89. PubMed ID: 11682251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
    Inoue O; Wakahara S; Kobayashi K; Gee A
    J Neural Transm (Vienna); 1999; 106(2):131-7. PubMed ID: 10226933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN
    Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
    Stenfors C; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):479-86. PubMed ID: 11692232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
    Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on the release of different neurotransmitters.
    Sitges M; Reyes A
    J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
    Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
    Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.
    Bischoff S; Gunst F
    J Recept Signal Transduct Res; 1997; 17(1-3):419-31. PubMed ID: 9029505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
    Ostergaard SD; Alstrup AK; Gramsbergen JB; Minuzzi L; Pedersen K; Jensen SB; Doudet D; Cumming P
    Synapse; 2010 Jan; 64(1):70-82. PubMed ID: 19768811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
    Shotbolt P; Tziortzi AC; Searle GE; Colasanti A; van der Aart J; Abanades S; Plisson C; Miller SR; Huiban M; Beaver JD; Gunn RN; Laruelle M; Rabiner EA
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):127-36. PubMed ID: 21878947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P; Tallerico T; Ko F
    Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA; Chu A; Sibley DR
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY-100635 has high selectivity for serotonin 5-HT(1A) versus dopamine D(4) receptors.
    Martel JC; Leduc N; Ormière AM; Faucillon V; Danty N; Culie C; Cussac D; Newman-Tancredi A
    Eur J Pharmacol; 2007 Nov; 574(1):15-9. PubMed ID: 17854799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.